Clinical trial
Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or…
NCT00103792 · University Medical Center Groningen, Other · Completed
Key facts
| NCT number | NCT00103792 |
|---|---|
| Title | Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA) |
| Official title | Comparative Study of the Efficacy of Induction Therapy With Cyclophosphamide or Mycophenolate Mofetil for Non-life-threatening Relapses of PR3- or MPO-ANCA Associated Vasculitis |
| Lead sponsor | University Medical Center Groningen, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Wegener's Granulomatosis, Vasculitis |
| Intervention type | Drug |
| Interventions | mycophenolate mofetil, cyclophosphamide |
| Enrollment | 84 |
| Start date | Dec 1, 2004 |
| Primary completion | Dec 1, 2014 |
| Completion | Jan 1, 2015 |
| First posted | Feb 15, 2005 |
| Last update posted | Aug 27, 2024 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: